Patient Capital Management, LLC Royalty Pharma PLC Transaction History
Patient Capital Management, LLC
- $1.75 Billion
- Q1 2025
A detailed history of Patient Capital Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Patient Capital Management, LLC holds 2,972,646 shares of RPRX stock, worth $105 Million. This represents 5.29% of its overall portfolio holdings.
Number of Shares
2,972,646
Previous 2,875,089
3.39%
Holding current value
$105 Million
Previous $73.3 Million
26.17%
% of portfolio
5.29%
Previous 3.76%
Shares
6 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.45 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.29 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$812 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$473 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$429 Million0.52% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...